Clinical Trial: An Open-label, Randomized, Single-dose, Two-treatment, Four-period, Fully Replicate Crossover Bioequivalence Study in Healthy Female Adult Participants Under Fasting Conditions Comparing the Test Product, Prontogest Solution for IM Injection With the Reference Product, Progesterone Injection

U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT07495007) titled 'An Open-label, Randomized, Single-dose, Two-treatment, Four-period, Fully Replicate Crossover Bioequivalence Study in Healthy Female Adult Participants Under Fasting Conditions Comparing the Test Product, Prontogest Solution for IM Injection With the Reference Product, Progesterone Injection' on March 06.

Brief Summary: Bioequivalence study of two injectable formulation of progesterone in healthy post-menopausal women

Study Start Date: Nov. 10, 2025

Study Type: INTERVENTIONAL

Condition: Bioequivalance Post-menopause

Intervention: DRUG: Progesterone IM of 100 mg

Test Product

DRUG: Progesterone IM of 100 mg

Reference product...